237 related articles for article (PubMed ID: 38629637)
1. RNA m6A modification, signals for degradation or stabilisation?
Wei G
Biochem Soc Trans; 2024 Apr; 52(2):707-717. PubMed ID: 38629637
[TBL] [Abstract][Full Text] [Related]
2. METTL3 and ALKBH5 oppositely regulate m
Song H; Feng X; Zhang H; Luo Y; Huang J; Lin M; Jin J; Ding X; Wu S; Huang H; Yu T; Zhang M; Hong H; Yao S; Zhao Y; Zhang Z
Autophagy; 2019 Aug; 15(8):1419-1437. PubMed ID: 30870073
[TBL] [Abstract][Full Text] [Related]
3. m
Takemoto S; Nakano M; Fukami T; Nakajima M
Biochem Pharmacol; 2021 Nov; 193():114766. PubMed ID: 34536357
[TBL] [Abstract][Full Text] [Related]
4. Fusaric acid decreases p53 expression by altering promoter methylation and m6A RNA methylation in human hepatocellular carcinoma (HepG2) cells.
Ghazi T; Nagiah S; Chuturgoon AA
Epigenetics; 2021 Jan; 16(1):79-91. PubMed ID: 32631113
[TBL] [Abstract][Full Text] [Related]
5. Epitranscriptomic editing of the RNA N6-methyladenosine modification by dCasRx conjugated methyltransferase and demethylase.
Xia Z; Tang M; Ma J; Zhang H; Gimple RC; Prager BC; Tang H; Sun C; Liu F; Lin P; Mei Y; Du R; Rich JN; Xie Q
Nucleic Acids Res; 2021 Jul; 49(13):7361-7374. PubMed ID: 34181729
[TBL] [Abstract][Full Text] [Related]
6. m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer.
Petri BJ; Klinge CM
J Mol Endocrinol; 2023 Feb; 70(2):. PubMed ID: 36367225
[TBL] [Abstract][Full Text] [Related]
7. m6A Regulators in Human Adipose Tissue - Depot-Specificity and Correlation With Obesity.
Rønningen T; Dahl MB; Valderhaug TG; Cayir A; Keller M; Tönjes A; Blüher M; Böttcher Y
Front Endocrinol (Lausanne); 2021; 12():778875. PubMed ID: 34950106
[TBL] [Abstract][Full Text] [Related]
8. Role of N6-methyladenosine modification in pathogenesis of ischemic stroke.
Chang H; Yang J; Wang Q; Zhao J; Zhu R
Expert Rev Mol Diagn; 2022 Mar; 22(3):295-303. PubMed ID: 35236212
[TBL] [Abstract][Full Text] [Related]
9. N(6)-Methyladenosine: a conformational marker that regulates the substrate specificity of human demethylases FTO and ALKBH5.
Zou S; Toh JD; Wong KH; Gao YG; Hong W; Woon EC
Sci Rep; 2016 May; 6():25677. PubMed ID: 27156733
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer.
Condic M; Ralser DJ; Klümper N; Ellinger J; Qureischi M; Egger EK; Kristiansen G; Mustea A; Thiesler T
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806168
[TBL] [Abstract][Full Text] [Related]
11. The comprehensive interactomes of human adenosine RNA methyltransferases and demethylases reveal distinct functional and regulatory features.
Covelo-Molares H; Obrdlik A; Poštulková I; Dohnálková M; Gregorová P; Ganji R; Potěšil D; Gawriyski L; Varjosalo M; Vaňáčová Š
Nucleic Acids Res; 2021 Nov; 49(19):10895-10910. PubMed ID: 34634806
[TBL] [Abstract][Full Text] [Related]
12. Dynamic RNA modifications in disease.
Klungland A; Dahl JA
Curr Opin Genet Dev; 2014 Jun; 26():47-52. PubMed ID: 25005745
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation of mRNA N6-methyladenosine modifications in mammalian gametogenesis.
Fang F; Wang X; Li Z; Ni K; Xiong C
Mol Hum Reprod; 2021 May; 27(5):. PubMed ID: 33823008
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of m6A-factors METTL3, ALKBH5, and YTHDC1 alters HPV16 mRNA splicing.
Cui X; Nilsson K; Kajitani N; Schwartz S
Virus Genes; 2022 Apr; 58(2):98-112. PubMed ID: 35190939
[TBL] [Abstract][Full Text] [Related]
15. N6-Methyladenosine detected in RNA of testicular germ cell tumors is controlled by METTL3, ALKBH5, YTHDC1/F1/F2, and HNRNPC as writers, erasers, and readers.
Nettersheim D; Berger D; Jostes S; Kristiansen G; Lochnit G; Schorle H
Andrology; 2019 Jul; 7(4):498-506. PubMed ID: 30903744
[TBL] [Abstract][Full Text] [Related]
16. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L
J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987
[TBL] [Abstract][Full Text] [Related]
17. N6-methyladenosine RNA modification (m6A) is of prognostic value in HPV-dependent vulvar squamous cell carcinoma.
Condic M; Thiesler T; Staerk C; Klümper N; Ellinger J; Egger EK; Kübler K; Kristiansen G; Mustea A; Ralser DJ
BMC Cancer; 2022 Sep; 22(1):943. PubMed ID: 36050747
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B Virus X Protein Expression Is Tightly Regulated by N6-Methyladenosine Modification of Its mRNA.
Kim GW; Siddiqui A
J Virol; 2022 Feb; 96(4):e0165521. PubMed ID: 34851655
[TBL] [Abstract][Full Text] [Related]
19. Glucose Is Involved in the Dynamic Regulation of m6A in Patients With Type 2 Diabetes.
Yang Y; Shen F; Huang W; Qin S; Huang JT; Sergi C; Yuan BF; Liu SM
J Clin Endocrinol Metab; 2019 Mar; 104(3):665-673. PubMed ID: 30137347
[TBL] [Abstract][Full Text] [Related]
20. Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer.
Zhang C; Zhang M; Ge S; Huang W; Lin X; Gao J; Gong J; Shen L
Cancer Med; 2019 Aug; 8(10):4766-4781. PubMed ID: 31243897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
